Fagron NV is a leading healthcare company based in Belgium with a Risk Rating Score of 9.5. The company specializes in pharmaceutical compounding and supplies pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. Fagron NV also manufactures pharmaceutical raw materials and equipment for medication preparation. Its revenue is primarily generated from Fagron North America. With a negligible risk assessment, Fagron NV is committed to ESG practices in environment, sustainability, and governance.